British American Tobacco gains as buyback support and reduced-risk optimism lift sentiment

British American Tobacco (BTI) is up 4.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of company-specific support and broader improved sentiment around nicotine alternatives. BAT recently reaffirmed its 2026 outlook, highlighted strong U.S. delivery and faster growth in newer categories, and is actively repurchasing shares ahead of half-year results, which can help support the stock. ([bat.com](https://www.bat.com/media/press-releases/_2026/june/2026-first-half-pre-close-trading-update?utm_source=openai))

Details:

BAT said on June 2 that it remains on track for full-year guidance, with performance expected at the lower end of its ranges, while pointing to continued U.S. strength and accelerating growth in modern oral and vapor products. ([bat.com](https://www.bat.com/media/press-releases/_2026/june/2026-first-half-pre-close-trading-update?utm_source=openai))

The company also said it expects mid-teens revenue growth in New Categories for both the first half and full year, suggesting investors may be giving more credit to its non-combustible portfolio. ([bat.com](https://www.bat.com/media/press-releases/_2026/june/2026-first-half-pre-close-trading-update?utm_source=openai))

BAT entered a closed-period share buyback arrangement running from June 30 to July 29, ahead of its half-year results, which are scheduled for July 30; ongoing repurchases can tighten share supply and improve sentiment. ([investegate.co.uk](https://www.investegate.co.uk/announcement/rns/british-american-tobacco--bats/share-buyback-programme/9638041?utm_source=openai))

A further tailwind may be better regulatory sentiment for nicotine pouches after recent U.S. action allowing specific modified-risk marketing claims for ZYN products, which could be lifting the broader reduced-risk tobacco group. This could be because investors see a friendlier backdrop for oral nicotine products. ([fda.gov](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-20-zyn-nicotine-pouches-be-marketed-specific-modified-risk-claim?utm_source=openai))

Sources:

British American Tobacco, SEC, FDA

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive BTI Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$BTI Hedge Fund Activity

We have seen 451 institutional investors add shares of $BTI stock to their portfolio, and 262 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL INTERNATIONAL INVESTORS removed 15,573,911 shares (-24.2%) from their portfolio in Q1 2026, for an estimated $910,606,576
CAPITAL RESEARCH GLOBAL INVESTORS added 8,629,499 shares (+38.6%) to their portfolio in Q1 2026, for an estimated $504,566,806
BLACKROCK, INC. added 8,518,913 shares (+80.2%) to their portfolio in Q1 2026, for an estimated $498,100,843
FMR LLC added 5,592,777 shares (+18.0%) to their portfolio in Q1 2026, for an estimated $327,009,671
JONES FINANCIAL COMPANIES LLLP added 3,766,004 shares (+3117.1%) to their portfolio in Q1 2026, for an estimated $220,198,253
CONTRARIUS GROUP HOLDINGS LTD added 2,823,441 shares (+inf%) to their portfolio in Q1 2026, for an estimated $165,086,595
BANK OF AMERICA CORP /DE/ added 2,494,576 shares (+34.4%) to their portfolio in Q1 2026, for an estimated $145,857,858

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.